However, data of 714 patients (212 IDH-wt GBM and 502 IDH-mut astrocytoma) was accumulated which exceeds the usual patient number of large clinical trials and adds significant accuracy to the effect estimations of individual studies. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).